ImportRefusal LogoImportRefusal

Lativio Llp

⚠️ Moderate Risk

FEI: 3006205650 • Nottinghamnottingham • UNITED KINGDOM

FEI

FEI Number

3006205650

📍

Location

Nottinghamnottingham

🇬🇧
🏢

Address

Suite 3a, Park Lane Business Centre, , Nottinghamnottingham, , United Kingdom

Moderate Risk

FDA Import Risk Assessment

49.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

12
Total Refusals
4
Unique Violations
2/5/2010
Latest Refusal
12/7/2009
Earliest Refusal

Score Breakdown

Violation Severity
68.2×40%
Refusal Volume
41.3×30%
Recency
0.0×20%
Frequency
100.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1611×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

5082×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

1171×

DANGEROUS

The article appears to be dangerous to health when used in the dosage or manner, or with the frequency or duration, prescribed, recommended, or suggested in the labeling thereof.

Refusal History

DateProductViolationsDivision
2/5/2010
89ISDEXERCISER, MEASURING
118NOT LISTED
16DIRECTIONS
Cincinnati District Office (CIN-DO)
1/11/2010
78JCWPROSTHESIS, PENIS, INFLATABLE
117DANGEROUS
118NOT LISTED
508NO 510(K)
Cincinnati District Office (CIN-DO)
1/7/2010
78JCWPROSTHESIS, PENIS, INFLATABLE
16DIRECTIONS
Cincinnati District Office (CIN-DO)
1/6/2010
78LKYDEVICE, EXTERNAL PENILE RIGIDITY
16DIRECTIONS
Cincinnati District Office (CIN-DO)
1/4/2010
78LKYDEVICE, EXTERNAL PENILE RIGIDITY
16DIRECTIONS
Cincinnati District Office (CIN-DO)
12/28/2009
78JCWPROSTHESIS, PENIS, INFLATABLE
16DIRECTIONS
Cincinnati District Office (CIN-DO)
12/28/2009
78LKYDEVICE, EXTERNAL PENILE RIGIDITY
16DIRECTIONS
Cincinnati District Office (CIN-DO)
12/28/2009
78LKYDEVICE, EXTERNAL PENILE RIGIDITY
16DIRECTIONS
Cincinnati District Office (CIN-DO)
12/23/2009
89IODCOMPONENTS, EXERCISE
16DIRECTIONS
Cincinnati District Office (CIN-DO)
12/23/2009
89IODCOMPONENTS, EXERCISE
16DIRECTIONS
Cincinnati District Office (CIN-DO)
12/10/2009
78JCWPROSTHESIS, PENIS, INFLATABLE
16DIRECTIONS
Cincinnati District Office (CIN-DO)
12/7/2009
78LKYDEVICE, EXTERNAL PENILE RIGIDITY
118NOT LISTED
16DIRECTIONS
508NO 510(K)
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Lativio Llp's FDA import refusal history?

Lativio Llp (FEI: 3006205650) has 12 FDA import refusal record(s) in our database, spanning from 12/7/2009 to 2/5/2010.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Lativio Llp's FEI number is 3006205650.

What types of violations has Lativio Llp received?

Lativio Llp has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Lativio Llp come from?

All FDA import refusal data for Lativio Llp is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.